Canada Biotechnology & Medical Research

Definium Therapeutics Inc (DFTX)

Track

Track

Definium Therapeutics Inc. experienced significant insider trading activity over the past ninety days, totaling over six million dollars in sales. Executives, including the CEO and CFO, executed multiple planned and proposed divestments. These actions follow a recent earnings report that missed expectations, occurring amidst a fifteen percent decline in stock value during this period.
Ticker: DFTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Karlin Daniel Chief Medical Officer Executive Director
Transaction date
Planned sale
Price
204.45
Quantity 38,332 -13.9%
Value US$2,100,828
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
431.43
Quantity 30,918 -41.7%
Value US$3,446,072
Wiley Matthew T. Chief Commercial Officer Officer
Transaction date
Planned sale
Price
96.71
Quantity 5,295 -8.1%
Value US$1,874,095
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
36.57
Quantity 1,000 -2.8%
Value US$100,000
Roberts Brandi Chief Financial Officer Officer
Transaction date
Planned sale
Price
36.57
Quantity 1,000 -0.8%
Value US$100,000
3.6
MARK SULLIVAN Officer Officer
Transaction date
Proposed sale
Price
36.73
Quantity 14,051
Value US$516,093
BRANDI ROBERTS Officer Officer
Transaction date
Proposed sale
Price
36.73
Quantity 3,377
Value US$124,037
MATTHEW THOMAS WILEY Officer Officer
Transaction date
Proposed sale
Price
36.73
Quantity 3,097
Value US$113,753
3.3
DANIEL ROLLINGS KARLIN Officer Officer
Transaction date
Proposed sale
Price
36.73
Quantity 10,853
Value US$398,631
3.2
ROBERT B BARROW Officer; Director Executive Director
Transaction date
Proposed sale
Price
36.73
Quantity 31,550
Value US$1,158,832
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
37.94
Quantity 19,023 -1.3%
Value US$721,733
3.2
ROBERT B BARROW Officer; Director Executive Director
Transaction date
Proposed sale
Price
37.75
Quantity 19,023
Value US$718,145
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
45.03
Quantity 29,208 -2.6%
Value US$1,315,236
Wiley Matthew T. Chief Commercial Officer Officer
Transaction date
Planned sale
Price
45.03
Quantity 2,867 -1.6%
Value US$129,101
Roberts Brandi Chief Financial Officer Officer
Transaction date
Planned sale
Price
45.03
Quantity 3,013 -1.4%
Value US$135,675
3.3
Karlin Daniel Chief Medical Officer Officer
Transaction date
Planned sale
Price
45.03
Quantity 10,035 -2.0%
Value US$451,876
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
45.03
Quantity 13,008 -3.9%
Value US$585,750
MATTHEW THOMAS WILEY Officer Officer
Transaction date
Proposed sale
Price
42.13
Quantity 2,867
Value US$120,787
3.6
MARK SULLIVAN Officer Officer
Transaction date
Proposed sale
Price
42.13
Quantity 13,008
Value US$548,027
BRANDI ROBERTS Officer Officer
Transaction date
Proposed sale
Price
42.13
Quantity 3,013
Value US$126,938
3.3
DANIEL ROLLINGS KARLIN Officer Officer
Transaction date
Proposed sale
Price
42.13
Quantity 10,035
Value US$422,775
3.2
ROBERT B BARROW Officer; Director Executive Director
Transaction date
Proposed sale
Price
42.13
Quantity 29,208
Value US$1,230,533
3.3
Karlin Daniel Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.47
Quantity 8,018 -1.9%
Value US$148,092
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.47
Quantity 10,702 -3.8%
Value US$197,666
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
18.47
Quantity 24,431 -3.1%
Value US$451,241
3.3
DANIEL ROLLINGS KARLIN Officer Officer
Transaction date
Proposed sale
Price
18.47
Quantity 8,018
Value US$148,092
3.2
ROBERT B BARROW Officer; Director Executive Director
Transaction date
Proposed sale
Price
18.47
Quantity 24,431
Value US$451,241
3.6
MARK SULLIVAN Officer Officer
Transaction date
Proposed sale
Price
18.47
Quantity 10,702
Value US$197,666
3.3
Karlin, Dan Officer Officer
Transaction date
Proposed sale
Price
13.15
Quantity 5,600
Value US$73,623
3.6
Sullivan, Mark Officer Officer
Transaction date
Proposed sale
Price
13.15
Quantity 11,276
Value US$148,244
3.2
Barrow, Robert Officer, Director Executive Director
Transaction date
Proposed sale
Price
13.15
Quantity 25,791
Value US$339,072
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
13.15
Quantity 25,791 -3.2%
Value US$339,072
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
13.15
Quantity 11,276 -3.8%
Value US$148,244
3.3
Karlin Daniel Chief Medical Officer Officer
Transaction date
Planned sale
Price
13.15
Quantity 5,600 -1.3%
Value US$73,623
3.3
Karlin Daniel Chief Medical Officer Officer
Transaction date
Planned sale
Price
9.77
Quantity 7,704 -1.8%
Value US$75,268
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
9.77
Quantity 11,278 -3.7%
Value US$110,186
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
9.77
Quantity 25,797 -3.1%
Value US$252,037
3.6
MARK SULLIVAN Officer Officer
Transaction date
Proposed sale
Price
9.77
Quantity 11,278
Value US$110,217
3.3
DANIEL ROLLINGS KARLIN Officer Officer
Transaction date
Proposed sale
Price
9.77
Quantity 7,704
Value US$75,289
3.2
ROBERT B BARROW Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.77
Quantity 25,797
Value US$252,106
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
6.80
Quantity 26,491 -3.1%
Value US$180,139
3.3
Karlin Daniel Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.80
Quantity 7,848 -1.8%
Value US$53,366
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
6.80
Quantity 11,491 -3.6%
Value US$78,139
3.3
DANIEL ROLLINGS KARLIN Officer Officer
Transaction date
Proposed sale
Price
6.80
Quantity 7,848
Value US$53,388
3.6
MARK SULLIVAN Officer Officer
Transaction date
Proposed sale
Price
6.80
Quantity 11,491
Value US$78,170
3.2
ROBERT B BARROW Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.80
Quantity 26,491
Value US$180,210
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
6.74
Quantity 6,576 -2.0%
Value US$44,322
Liao Carrie Chief Accounting Officer Officer
Transaction date
Planned sale
Price
6.74
Quantity 2,347 -1.6%
Value US$15,819
3.3
Karlin Daniel Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.74
Quantity 6,836 -1.5%
Value US$46,075
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
6.74
Quantity 21,208 -2.4%
Value US$142,942
3.6
MARK SULLIVAN Officer Officer
Transaction date
Proposed sale
Price
6.74
Quantity 6,576
Value US$44,304
CARRIE LIAO Officer Officer
Transaction date
Proposed sale
Price
6.74
Quantity 2,347
Value US$15,812
3.2
ROBERT B BARROW Officer; Director Executive Director
Transaction date
Proposed sale
Price
6.74
Quantity 21,208
Value US$142,883
3.3
DANIEL ROLLINGS KARLIN Officer Officer
Transaction date
Proposed sale
Price
6.74
Quantity 6,836
Value US$46,056
3.3
Karlin Dan Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.43
Quantity 6,643 -1.9%
Value US$49,357
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
7.43
Quantity 19,106 -3.5%
Value US$141,958
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.43
Quantity 4,519 -2.5%
Value US$33,576
Liao Carrie Chief Accounting Officer Officer
Transaction date
Planned sale
Price
7.43
Quantity 2,273 -2.3%
Value US$16,888
3.2
ROBERT B BARROW Officer Officer
Transaction date
Proposed sale
Price
7.43
Quantity 19,106
Value US$141,979
3.6
MARK SULLIVAN Officer Officer
Transaction date
Proposed sale
Price
7.43
Quantity 4,519
Value US$33,581
3.3
DAN ROLLINGS KARLIN Officer Officer
Transaction date
Proposed sale
Price
7.43
Quantity 6,643
Value US$49,365
CARRIE LIAO Officer Officer
Transaction date
Proposed sale
Price
7.43
Quantity 2,273
Value US$16,891
2.4
GRYSKA DAVID W Non-Executive Director
Transaction date
Purchase
Price
7.17
Quantity 2,500 +14.4%
Value US$17,925
3.6
Sullivan, Mark Officer Officer
Transaction date
Proposed sale
Price
5.98
Quantity 4,430
Value US$26,487
3.3
Karlin, Dan Officer Officer
Transaction date
Proposed sale
Price
5.98
Quantity 6,871
Value US$41,081
3.2
Barrow, Robert Officer, Director Executive Director
Transaction date
Proposed sale
Price
5.98
Quantity 19,771
Value US$118,210
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.98
Quantity 19,771 -3.5%
Value US$118,231
3.3
Karlin Dan Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.98
Quantity 6,871 -2.0%
Value US$41,089
3.6
Sullivan Mark Chief Legal Officer Officer
Transaction date
Planned sale
Price
5.98
Quantity 4,430 -2.4%
Value US$26,491
Liao Carrie Chief Accounting Officer Officer
Transaction date
Planned sale
Price
5.98
Quantity 2,352 -2.3%
Value US$14,065
2.4
GRYSKA DAVID W Non-Executive Director
Transaction date
Purchase
Price
5.98
Quantity 3,500 +25.3%
Value US$20,930
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Purchase
Price
6.12
Quantity 500 +0.1%
Value US$3,060
3.2
Barrow Robert Chief Executive Officer Executive Director
Transaction date
Purchase
Price
6.31
Quantity 500 +0.1%
Value US$3,155
3.6
Sullivan, Mark Officer Officer
Transaction date
Proposed sale
Price
7.22
Quantity 17,854
Value US$128,979
3.2
Barrow, Robert Officer, Director Executive Director
Transaction date
Proposed sale
Price
7.22
Quantity 15,659
Value US$113,122
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-29 2026-09-25 PlS Planned sale
3.3
Karlin Daniel

Chief Medical Officer

Executive Director
38,332 -13.9%
204.45
US$2,100,828 		38,332 -13.9% 204.45 US$2,100,828
2026-09-29 2026-09-25 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
30,918 -41.7%
431.43
US$3,446,072 		30,918 -41.7% 431.43 US$3,446,072
2026-09-29 2026-09-25 PlS Planned sale
Wiley Matthew T.

Chief Commercial Officer

Officer
5,295 -8.1%
96.71
US$1,874,095 		5,295 -8.1% 96.71 US$1,874,095
2026-09-29 2026-09-25 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
1,000 -2.8%
36.57
US$100,000 		1,000 -2.8% 36.57 US$100,000
2026-09-29 2026-09-25 PlS Planned sale
Roberts Brandi

Chief Financial Officer

Officer
1,000 -0.8%
36.57
US$100,000 		1,000 -0.8% 36.57 US$100,000
2026-09-25 2026-09-25 PrS Proposed sale
3.6
MARK SULLIVAN

Officer

Officer
14,051
36.73
US$516,093 		14,051 36.73 US$516,093
2026-09-25 2026-09-25 PrS Proposed sale
BRANDI ROBERTS

Officer

Officer
3,377
36.73
US$124,037 		3,377 36.73 US$124,037
2026-09-25 2026-09-25 PrS Proposed sale
MATTHEW THOMAS WILEY

Officer

Officer
3,097
36.73
US$113,753 		3,097 36.73 US$113,753
2026-09-25 2026-09-25 PrS Proposed sale
3.3
DANIEL ROLLINGS KARLIN

Officer

Officer
10,853
36.73
US$398,631 		10,853 36.73 US$398,631
2026-09-25 2026-09-25 PrS Proposed sale
3.2
ROBERT B BARROW

Officer; Director

Executive Director
31,550
36.73
US$1,158,832 		31,550 36.73 US$1,158,832
2026-09-04 2026-09-03 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
19,023 -1.3%
37.94
US$721,733 		19,023 -1.3% 37.94 US$721,733
2026-09-03 2026-09-03 PrS Proposed sale
3.2
ROBERT B BARROW

Officer; Director

Executive Director
19,023
37.75
US$718,145 		19,023 37.75 US$718,145
2026-06-26 2026-06-25 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
29,208 -2.6%
45.03
US$1,315,236 		29,208 -2.6% 45.03 US$1,315,236
2026-06-26 2026-06-25 PlS Planned sale
Wiley Matthew T.

Chief Commercial Officer

Officer
2,867 -1.6%
45.03
US$129,101 		2,867 -1.6% 45.03 US$129,101
2026-06-26 2026-06-25 PlS Planned sale
Roberts Brandi

Chief Financial Officer

Officer
3,013 -1.4%
45.03
US$135,675 		3,013 -1.4% 45.03 US$135,675
2026-06-26 2026-06-25 PlS Planned sale
3.3
Karlin Daniel

Chief Medical Officer

Officer
10,035 -2.0%
45.03
US$451,876 		10,035 -2.0% 45.03 US$451,876
2026-06-26 2026-06-25 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
13,008 -3.9%
45.03
US$585,750 		13,008 -3.9% 45.03 US$585,750
2026-06-25 2026-06-25 PrS Proposed sale
MATTHEW THOMAS WILEY

Officer

Officer
2,867
42.13
US$120,787 		2,867 42.13 US$120,787
2026-06-25 2026-06-25 PrS Proposed sale
3.6
MARK SULLIVAN

Officer

Officer
13,008
42.13
US$548,027 		13,008 42.13 US$548,027
2026-06-25 2026-06-25 PrS Proposed sale
BRANDI ROBERTS

Officer

Officer
3,013
42.13
US$126,938 		3,013 42.13 US$126,938
2026-06-25 2026-06-25 PrS Proposed sale
3.3
DANIEL ROLLINGS KARLIN

Officer

Officer
10,035
42.13
US$422,775 		10,035 42.13 US$422,775
2026-06-25 2026-06-25 PrS Proposed sale
3.2
ROBERT B BARROW

Officer; Director

Executive Director
29,208
42.13
US$1,230,533 		29,208 42.13 US$1,230,533
2026-03-26 2026-03-25 PlS Planned sale
3.3
Karlin Daniel

Chief Medical Officer

Officer
8,018 -1.9%
18.47
US$148,092 		8,018 -1.9% 18.47 US$148,092
2026-03-26 2026-03-25 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
10,702 -3.8%
18.47
US$197,666 		10,702 -3.8% 18.47 US$197,666
2026-03-26 2026-03-25 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
24,431 -3.1%
18.47
US$451,241 		24,431 -3.1% 18.47 US$451,241
2026-03-25 2026-03-25 PrS Proposed sale
3.3
DANIEL ROLLINGS KARLIN

Officer

Officer
8,018
18.47
US$148,092 		8,018 18.47 US$148,092
2026-03-25 2026-03-25 PrS Proposed sale
3.2
ROBERT B BARROW

Officer; Director

Executive Director
24,431
18.47
US$451,241 		24,431 18.47 US$451,241
2026-03-25 2026-03-25 PrS Proposed sale
3.6
MARK SULLIVAN

Officer

Officer
10,702
18.47
US$197,666 		10,702 18.47 US$197,666
2025-12-29 2025-12-26 PrS Proposed sale
3.3
Karlin, Dan

Officer

Officer
5,600
13.15
US$73,623 		5,600 13.15 US$73,623
2025-12-29 2025-12-26 PrS Proposed sale
3.6
Sullivan, Mark

Officer

Officer
11,276
13.15
US$148,244 		11,276 13.15 US$148,244
2025-12-29 2025-12-26 PrS Proposed sale
3.2
Barrow, Robert

Officer, Director

Executive Director
25,791
13.15
US$339,072 		25,791 13.15 US$339,072
2025-12-29 2025-12-26 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
25,791 -3.2%
13.15
US$339,072 		25,791 -3.2% 13.15 US$339,072
2025-12-29 2025-12-26 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
11,276 -3.8%
13.15
US$148,244 		11,276 -3.8% 13.15 US$148,244
2025-12-29 2025-12-26 PlS Planned sale
3.3
Karlin Daniel

Chief Medical Officer

Officer
5,600 -1.3%
13.15
US$73,623 		5,600 -1.3% 13.15 US$73,623
2025-09-26 2025-09-25 PlS Planned sale
3.3
Karlin Daniel

Chief Medical Officer

Officer
7,704 -1.8%
9.77
US$75,268 		7,704 -1.8% 9.77 US$75,268
2025-09-26 2025-09-25 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
11,278 -3.7%
9.77
US$110,186 		11,278 -3.7% 9.77 US$110,186
2025-09-26 2025-09-25 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
25,797 -3.1%
9.77
US$252,037 		25,797 -3.1% 9.77 US$252,037
2025-09-25 2025-09-25 PrS Proposed sale
3.6
MARK SULLIVAN

Officer

Officer
11,278
9.77
US$110,217 		11,278 9.77 US$110,217
2025-09-25 2025-09-25 PrS Proposed sale
3.3
DANIEL ROLLINGS KARLIN

Officer

Officer
7,704
9.77
US$75,289 		7,704 9.77 US$75,289
2025-09-25 2025-09-25 PrS Proposed sale
3.2
ROBERT B BARROW

Officer; Director

Executive Director
25,797
9.77
US$252,106 		25,797 9.77 US$252,106
2025-06-26 2025-06-25 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
26,491 -3.1%
6.80
US$180,139 		26,491 -3.1% 6.80 US$180,139
2025-06-26 2025-06-25 PlS Planned sale
3.3
Karlin Daniel

Chief Medical Officer

Officer
7,848 -1.8%
6.80
US$53,366 		7,848 -1.8% 6.80 US$53,366
2025-06-26 2025-06-25 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
11,491 -3.6%
6.80
US$78,139 		11,491 -3.6% 6.80 US$78,139
2025-06-25 2025-06-25 PrS Proposed sale
3.3
DANIEL ROLLINGS KARLIN

Officer

Officer
7,848
6.80
US$53,388 		7,848 6.80 US$53,388
2025-06-25 2025-06-25 PrS Proposed sale
3.6
MARK SULLIVAN

Officer

Officer
11,491
6.80
US$78,170 		11,491 6.80 US$78,170
2025-06-25 2025-06-25 PrS Proposed sale
3.2
ROBERT B BARROW

Officer; Director

Executive Director
26,491
6.80
US$180,210 		26,491 6.80 US$180,210
2025-03-26 2025-03-25 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
6,576 -2.0%
6.74
US$44,322 		6,576 -2.0% 6.74 US$44,322
2025-03-26 2025-03-25 PlS Planned sale
Liao Carrie

Chief Accounting Officer

Officer
2,347 -1.6%
6.74
US$15,819 		2,347 -1.6% 6.74 US$15,819
2025-03-26 2025-03-25 PlS Planned sale
3.3
Karlin Daniel

Chief Medical Officer

Officer
6,836 -1.5%
6.74
US$46,075 		6,836 -1.5% 6.74 US$46,075
2025-03-26 2025-03-25 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
21,208 -2.4%
6.74
US$142,942 		21,208 -2.4% 6.74 US$142,942
2025-03-25 2025-03-25 PrS Proposed sale
3.6
MARK SULLIVAN

Officer

Officer
6,576
6.74
US$44,304 		6,576 6.74 US$44,304
2025-03-25 2025-03-25 PrS Proposed sale
CARRIE LIAO

Officer

Officer
2,347
6.74
US$15,812 		2,347 6.74 US$15,812
2025-03-25 2025-03-25 PrS Proposed sale
3.2
ROBERT B BARROW

Officer; Director

Executive Director
21,208
6.74
US$142,883 		21,208 6.74 US$142,883
2025-03-25 2025-03-25 PrS Proposed sale
3.3
DANIEL ROLLINGS KARLIN

Officer

Officer
6,836
6.74
US$46,056 		6,836 6.74 US$46,056
2024-12-27 2024-12-26 PlS Planned sale
3.3
Karlin Dan

Chief Medical Officer

Officer
6,643 -1.9%
7.43
US$49,357 		6,643 -1.9% 7.43 US$49,357
2024-12-27 2024-12-26 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
19,106 -3.5%
7.43
US$141,958 		19,106 -3.5% 7.43 US$141,958
2024-12-27 2024-12-26 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
4,519 -2.5%
7.43
US$33,576 		4,519 -2.5% 7.43 US$33,576
2024-12-27 2024-12-26 PlS Planned sale
Liao Carrie

Chief Accounting Officer

Officer
2,273 -2.3%
7.43
US$16,888 		2,273 -2.3% 7.43 US$16,888
2024-12-26 2024-12-26 PrS Proposed sale
3.2
ROBERT B BARROW

Officer

Officer
19,106
7.43
US$141,979 		19,106 7.43 US$141,979
2024-12-26 2024-12-26 PrS Proposed sale
3.6
MARK SULLIVAN

Officer

Officer
4,519
7.43
US$33,581 		4,519 7.43 US$33,581
2024-12-26 2024-12-26 PrS Proposed sale
3.3
DAN ROLLINGS KARLIN

Officer

Officer
6,643
7.43
US$49,365 		6,643 7.43 US$49,365
2024-12-26 2024-12-26 PrS Proposed sale
CARRIE LIAO

Officer

Officer
2,273
7.43
US$16,891 		2,273 7.43 US$16,891
2024-12-05 2024-12-05 B Purchase
2.4
GRYSKA DAVID W
Non-Executive Director
2,500 +14.4%
7.17
US$17,925 		2,500 +14.4% 7.17 US$17,925
2024-09-25 2024-09-25 PrS Proposed sale
3.6
Sullivan, Mark

Officer

Officer
4,430
5.98
US$26,487 		4,430 5.98 US$26,487
2024-09-25 2024-09-25 PrS Proposed sale
3.3
Karlin, Dan

Officer

Officer
6,871
5.98
US$41,081 		6,871 5.98 US$41,081
2024-09-25 2024-09-25 PrS Proposed sale
3.2
Barrow, Robert

Officer, Director

Executive Director
19,771
5.98
US$118,210 		19,771 5.98 US$118,210
2024-09-25 2024-09-25 PlS Planned sale
3.2
Barrow Robert

Chief Executive Officer

Executive Director
19,771 -3.5%
5.98
US$118,231 		19,771 -3.5% 5.98 US$118,231
2024-09-25 2024-09-25 PlS Planned sale
3.3
Karlin Dan

Chief Medical Officer

Officer
6,871 -2.0%
5.98
US$41,089 		6,871 -2.0% 5.98 US$41,089
2024-09-25 2024-09-25 PlS Planned sale
3.6
Sullivan Mark

Chief Legal Officer

Officer
4,430 -2.4%
5.98
US$26,491 		4,430 -2.4% 5.98 US$26,491
2024-09-25 2024-09-25 PlS Planned sale
Liao Carrie

Chief Accounting Officer

Officer
2,352 -2.3%
5.98
US$14,065 		2,352 -2.3% 5.98 US$14,065
2024-08-26 2024-08-23 B Purchase
2.4
GRYSKA DAVID W
Non-Executive Director
3,500 +25.3%
5.98
US$20,930 		3,500 +25.3% 5.98 US$20,930
2024-08-20 2024-08-20 B Purchase
3.2
Barrow Robert

Chief Executive Officer

Executive Director
500 +0.1%
6.12
US$3,060 		500 +0.1% 6.12 US$3,060
2024-08-20 2024-08-19 B Purchase
3.2
Barrow Robert

Chief Executive Officer

Executive Director
500 +0.1%
6.31
US$3,155 		500 +0.1% 6.31 US$3,155
2024-06-25 2024-06-25 PrS Proposed sale
3.6
Sullivan, Mark

Officer

Officer
17,854
7.22
US$128,979 		17,854 7.22 US$128,979
2024-06-25 2024-06-25 PrS Proposed sale
3.2
Barrow, Robert

Officer, Director

Executive Director
15,659
7.22
US$113,122 		15,659 7.22 US$113,122
Explore more

More insider trading research around Definium Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America